搜索临床试验以:抗PD-1/PD-L1单克隆抗体
总计2328个结果
-
Shandong Cancer Hospital and InstituteBeiGene主动,不招人
-
Roswell Park Cancer Institute撤销
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人转移性恶性实体瘤 | IV 期结肠癌 AJCC v8 | IV 期直肠癌 AJCC v8 | IVA 期结肠癌 AJCC v8 | IVA 期直肠癌 AJCC v8 | IVB 期结肠癌 AJCC v8 | IVB 期直肠癌 AJCC v8 | 直肠腺癌 | 结肠腺癌 | 高频微卫星不稳定性 | 难治性结直肠癌美国
-
Second Affiliated Hospital, School of Medicine,...招聘中
-
Shanghai Zhongshan HospitalZhejiang Cancer Hospital; Sun Yat-sen University; Cancer Institute and Hospital, Chinese Academy... 和其他合作者招聘中
-
Jinling Hospital, China招聘中肿瘤 | 肾脏肿瘤 | 癌,肾细胞 | 泌尿系肿瘤 | 泌尿生殖系统肿瘤 | 肾脏疾病 | 泌尿系统疾病 | 癌 | 抗肿瘤药 | 男性泌尿生殖系统疾病 | 女性泌尿生殖系统疾病 | 免疫检查点抑制剂 | 泌尿生殖系统疾病中国
-
Hangzhou Hanx Biopharmaceuticals, Ltd.Wuhan Hanxiong Bioscience, Ltd.主动,不招人
-
CellSight Technologies, Inc.Stanford University完全的
-
Shanghai Zhongshan HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Hangzhou Cancer HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Emory UniversityNational Cancer Institute (NCI)撤销预后 IV 期乳腺癌 AJCC v8 | 脑转移性恶性肿瘤 | 转移性乳腺癌 | IV 期乳腺癌美国癌症联合委员会 (AJCC) v8
-
The Second Affiliated Hospital of Chongqing Medical...Guizhou Provincial People's Hospital; The Affiliated Hospital Of Southwest Medical University尚未招聘
-
Zhejiang Cancer Hospital尚未招聘胃癌、HIPEC、抗 PD-1 抗体 Camrelizumab (SHR-1210)、化疗和手术中国
-
Peking University Cancer Hospital & Institute招聘中
-
German Breast GroupAstraZeneca; Celgene完全的
-
Glenn J. HannaImmunityBio, Inc.招聘中头颈癌 | 头颈部鳞状细胞癌 | 复发性头颈部鳞状细胞癌 | 复发性头颈癌 | 转移性头颈癌 | 转移性头颈部鳞状细胞癌美国
-
Lei Li招聘中复发性宫颈癌 | 放疗 | 免疫检查点抑制剂 | 总生存期 | 抗程序性死亡-1 抗体 | 转移性宫颈癌 | 持续性晚期宫颈癌 | 客观缓解率 | 无进展生存期 | 严重不良事件中国
-
Second Affiliated Hospital of Soochow University尚未招聘
-
Gustave Roussy, Cancer Campus, Grand Paris主动,不招人
-
National Cancer Institute (NCI)招聘中胃食管结合部 (GEJ) 癌 | 高级 HNSCC美国
-
M.D. Anderson Cancer Center主动,不招人
-
Hassane M. Zarour, MDMerck Sharp & Dohme LLC; Melanoma Research Alliance完全的